CompletedNot applicableNCT00007358

Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

Studying Congenital heart block

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: NYU Langone Health
Principal Investigator: Jill P. Buyon, MD
Hospital for Joint Diseases
Intervention: Dexamethasone or other corticosteroid(drug)
Enrollment: 150 enrolled
Eligibility: 16-50 years · FEMALE
Timeline: 2000 – 2008

Study locations (4)

Yale University Medical Center, New Haven, Connecticut, United States
St. Barnabas Medical Center, Livingston, New Jersey, United States
Hospital for Joint Diseases, New York, New York, United States
New York University Medical Center, New York, New York, United States

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00007358 on ClinicalTrials.gov

Other trials for Congenital heart block

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNCT06763549
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
Peerbridge Health, Inc

See all trials for Congenital heart block →

← Back to all trials